Comments

Intra-Cellular Therapies Stock Price, Quotes and Forecasts

Q: What sector and industry does Intra-Cellular Therapies (ITCI) operate in?

Intra-Cellular Therapies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

ITCINASDAQ

Intra-Cellular Therapies (ITCI) Forecast

News Earnings Intra-Cellular Therapies (ITCI) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Intra-Cellular Therapies Stock Price, Quotes and Forecasts | NASDAQ:ITCI | Benzinga

Explore Intra-Cellular Therapies stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ITCI.

Open	$131.75
Close	-
Volume / Avg.	217.33K / 3.11M
Day Range	$131.68 - $131.79
52 Wk Range	64.09 - 131.71
Market Cap	$14.03B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	85
Short Interest	2.22%
Days to Cover	1.38

Recent News

Johnson & Johnson Stops Late-Stage Depression Study Over 'Insufficient Efficacy'

Johnson & Johnson discontinues aticaprant's Phase 3 trial but explores future options. Another depression drug Spravato sales hit $1.01 billion

Vandana Singh

Nike To Rally Over 50%? Here Are 10 Top Analyst Forecasts For Monday

Avi Kapoor

This Conagra Brands Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$131.75
Close	-
Volume / Avg.	217.33K / 3.11M
Day Range	$131.68 - $131.79
52 Wk Range	64.09 - 131.71
Market Cap	$14.03B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	85
Short Interest	2.22%
Days to Cover	1.38

About Intra-Cellular Therapies Inc

Sector

Health Care

Industry

Pharmaceuticals

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating d...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Intra-Cellular Therapies (ITCI) stock?

You can purchase shares of Intra-Cellular Therapies (NASDAQ:ITCI) through any online brokerage.

View our list of the best stock brokerages

Who are Intra-Cellular Therapies (ITCI) competitors?

Other companies in Intra-Cellular Therapies’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA) and Novartis (NYSE:NVS).

What is the forecast, or price target, for Intra-Cellular Therapies (ITCI) stock?

Intra-Cellular Therapies has a consensus price target of $101.53.

What is the current price for Intra-Cellular Therapies (ITCI)?

The stock price for Intra-Cellular Therapies (NASDAQ: ITCI) is $131.71 last updated March 25, 2025 at 10:16 AM EDT.

Does Intra-Cellular Therapies (ITCI) pay a dividend?

There are no upcoming dividends for Intra-Cellular Therapies.

When is Intra-Cellular Therapies (NASDAQ:ITCI) reporting earnings?

Intra-Cellular Therapies’s Q1 earnings are confirmed for Tuesday, May 6, 2025.

Is Intra-Cellular Therapies (ITCI) going to split?

There is no upcoming split for Intra-Cellular Therapies.

What sector and industry does Intra-Cellular Therapies (ITCI) operate in?

Intra-Cellular Therapies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.